Skip to main content
. 2019 Jun 26;3(2):026106. doi: 10.1063/1.5091713

FIG. 3.

FIG. 3.

OvCa samples derived from patient ascites were encapsulated in 3D omentum-inspired PEG-MAL hydrogels for drug screening. (a) Pathology report of patient samples. (b) LIVE (green)/DEAD (red) imaging of OCAS in 3D omentum PEGMAL hydrogels one day postencapsulation. Scale bars = 100 μm. Images are representative from the sample. (c) Patient sample drug responses displayed as the log2 fold change in EC50 in the omentum hydrogel relative to EC50 on TCPS. Red and blue indicate the higher and lower EC50 values in the 3D omentum hydrogel relative to the EC50 on TCPS, respectively.